Folgen
Martin Werle
Martin Werle
Cyprumed GmbH
Bestätigte E-Mail-Adresse bei cyprumed.net
Titel
Zitiert von
Zitiert von
Jahr
Strategies to improve plasma half life time of peptide and protein drugs
M Werle, A Bernkop-Schnürch
Amino acids 30, 351-367, 2006
7722006
Natural and synthetic polymers as inhibitors of drug efflux pumps
M Werle
Pharmaceutical Research 25, 500-511, 2008
2292008
Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine
M Werle, M Hoffer
Journal of controlled release 111 (1-2), 41-46, 2006
1952006
Synthesis and in vitro evaluation of thiolated hyaluronic acid for mucoadhesive drug delivery
K Kafedjiiski, RKR Jetti, F Föger, H Hoyer, M Werle, M Hoffer, ...
International journal of pharmaceutics 343 (1-2), 48-58, 2007
1532007
A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa
A Makhlof, M Werle, Y Tozuka, H Takeuchi
Journal of controlled release 149 (1), 81-88, 2011
1512011
Modified chitosans for oral drug delivery
M Werle, H Takeuchi, A Bernkop-Schnürch
Journal of pharmaceutical sciences 98 (5), 1643-1656, 2009
1462009
Chitosan–aprotinin coated liposomes for oral peptide delivery: development, characterisation and in vivo evaluation
M Werle, H Takeuchi
International journal of pharmaceutics 370 (1-2), 26-32, 2009
1402009
Nanoparticles of glycol chitosan and its thiolated derivative significantly improved the pulmonary delivery of calcitonin
A Makhlof, M Werle, Y Tozuka, H Takeuchi
International journal of pharmaceutics 397 (1-2), 92-95, 2010
1342010
Synthesis and in Vitro Evaluation of a Novel Chitosan–Glutathione Conjugate
K Kafedjiiski, F Föger, M Werle, A Bernkop-Schnürch
Pharmaceutical research 22, 1480-1488, 2005
1272005
The potential of cystine-knot microproteins as novel pharmacophoric scaffolds in oral peptide drug delivery
M Werle, T Schmitz, HL Huang, A Wentzel, H Kolmar, ...
Journal of drug targeting 14 (3), 137-146, 2006
1132006
Thiolated chitosans: useful excipients for oral drug delivery
M Werle, A Bernkop‐Schnürch
Journal of Pharmacy and Pharmacology 60 (3), 273-281, 2008
962008
Improved synthesis and in vitro characterization of chitosan–thioethylamidine conjugate
K Kafedjiiski, M Hoffer, M Werle, A Bernkop-Schnürch
Biomaterials 27 (1), 127-135, 2006
772006
Evaluation and improvement of the properties of the novel cystine-knot microprotein McoEeTI for oral administration
M Werle, K Kafedjiiski, H Kolmar, A Bernkop-Schnürch
International journal of pharmaceutics 332 (1-2), 72-79, 2007
672007
Oral gene delivery: Strategies to improve stability of pDNA towards intestinal digestion
B Loretz, F Föger, M Werle, A Bernkop-Schnuerch
Journal of drug targeting 14 (5), 311-319, 2006
572006
Carbopol-lectin conjugate coated liposomes for oral peptide delivery
M Werle, A Makhlof, H Takeuchi
Chemical and Pharmaceutical Bulletin 58 (3), 432-434, 2010
472010
Oral protein delivery: a patent review of academic and industrial approaches
M Werle, A Makhlof, H Takeuchi
Recent patents on drug delivery & formulation 3 (2), 94-104, 2009
452009
Design and evaluation of a chitosan–aprotinin conjugate for the peroral delivery of therapeutic peptides and proteins susceptible to enzymatic degradation
M Werle, B Loretz, D Entstrasser, F Föger
Journal of drug targeting 15 (5), 327-333, 2007
312007
Mucoadhesive drug carriers and polymers for effective drug delivery
A Makhlof, M Werle, H Takeuchi
Journal of drug delivery science and technology 18 (6), 375-386, 2008
292008
Degradation of teriparatide by gastro-intestinal proteolytic enzymes
M Werle, A Samhaber, A Bernkop-Schnürch
Journal of drug targeting 14 (3), 109-115, 2006
292006
Effect of a thiolated polymer on oral paclitaxel absorption and tumor growth in rats
F Föger, S Malaivijitnond, T Wannaprasert, C Huck, A Bernkop-Schnürch, ...
Journal of drug targeting 16 (2), 149-155, 2008
282008
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20